30.11.2021
Е. В. Попова
the outbreak of the COVID-19 pandemic caused by a novel coronavirus SARS-CoV-2. Immunosuppressive drugs were
20.11.2021
В. Г. Цапаев; Н. Л. Цапаева
in the physiological processes of the body in COVID-19 are presented. Possible mechanisms of the use of omega-3 PUFAs
20.11.2021
О. А. Гальцова; А. Г. Захаренко
with the development of myocarditis is relevant in COVID-19. SARS-CoV-2 virus should be considered as the source
07.11.2021
Л. П. Титов; Т. В. Амвросьева; М. О. Трусевич; И. В. Бельская
COVID-19 has become a planetary emergency which is seriously threatening human health
08.10.2021
А. М. Малкова; A. A. Starshinovа; А. А. Старшинова; И. В. Кудрявцев; И. Ф. Довгалюк; Ю. С. Зинченко; Д. А. Кудлай
The high mortality rate in COVID-19 can be explained by the development of a hyperinflammatory
07.10.2021
И. Х. Борукаева; З. Х. Абазова; Ф. Х. Темиржанова; М. М. Юсупова
to develop an individualized approach to treating COVID-19. Questions were raised about the advisability
21.09.2021
А. С. Бавыкин
Cell and molecular level of strategy of COVID-19 to induce immunodeficiency. Possible therapeutic
17.09.2021
А. Д. Макацария; Е. В. Слуханчук; В. О. Бицадзе; Д. Х. Хизроева; М. В. Третьякова; А. С. Шкода; С. В. Акиньшина; Н. А. Макацария; В. И. Цибизова; Ж.-К. Гри; И. Элалами; С. Ay; Ц. Ай; Э. Грандоне
in COVID-19 patients. Key features related to such condition include minimal or no risk of bleeding
27.08.2021
Ю. С Полушин; И. В. Шлык; Е. Г. Гаврилова; Е. В. Паршин; А. М. Гинзбург
significantly especially in the severe course of COVID-19. Information on the effect of hyperferritinemia
07.08.2021
Е. В. Попова; М. И. Александров; И. А. Трубникова; С. Р. Зейналова
The COVID-19 pandemic was announced in 2020, and many professional medical societies had to review
